Early clinical experiences with mycophenolate mofetil for immunosuppressive therapy of ocular cicatrical pemphigoid;Erste klinische erfahrungen mit mycophenolatmofetil bei der immunsuppressiven therapie des okulären pemphigoids

Klinische Monatsblatter fur Augenheilkunde

Volumn 218, Issue 4, 2001, Pages 222-228

  Zurdel, Jan ^a   Aboalchamat, Bilal ^a   Zierhut, Manfred ^b   Stübiger, Nicole ^b   Bialasiewicz, Alexander ^a   Engelmann, Katrin ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Immunosuppression; Mycophenolate mofetil; Ocular cicatrical pemphigoid

Indexed keywords

CYCLOPHOSPHAMIDE; DAPSONE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; APPETITE DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL RESEARCH; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG RESEARCH; EYE DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MUCOUS MEMBRANE PEMPHIGOID; NAUSEA;

EID: 0035041510     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-14917     Document Type: Article

References (22)

1. Allison AC, Eugui EM. Immunsuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993; 136: 5-28.
2. Barry JM. Immunosuppressive Drugs in Renal Transplantation. Drugs 1992; 44: 554-566.
3. Berra A, Dutt JE, Nouri M, Foster CS. Heat shock protein expression in human conjunctiva. Invest Ophthalmol Vis Sci 1994; 35 (2): 352-357.
4. Chan RY, Bhol K, Tesavibul N, Letko E, Simmons RK, Foster CS, Ahmed AR. The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatrical pemphigoid. Invest Ophthalmol Vis Sci 1999; 40 (10): 2283-2290.
5. Elder MJ, Bernauer W, Leonard J, Dart JK. Progression of disease in ocular cicatrical pemphigoid. Br J Ophthalmol 1996; 80 (4): 292-296.
6. Elder MJ, Dart JK, Lightman S. Conjunctival fibrosis in ocular cicatrical pemphigoid-the role of cytokines. Exp Eye Res 1997; 65 (2): 165-176.
7. Epinette WW, Parker CM, Jones EL, Greist MC. Mycophenolic acid for psoriasis. J Am Acad Dermatol 1987; 17: 962-971.
8. Fern AI, Jay JL, Young H, MacKie R. Dapsone therapy for the acute inflammatory phase of ocular pemphigoid. Br J Ophthalmol 1992; 76: 332-335.
9. Foster CS. Cicatrical pemphigoid. Trans Am Ophthalmol Soc 1986; 84: 527-663.
10. Goldblum R. Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin Exp Rheumatol 1993; 11: S117-119.
11. Heiligenhaus A, Schaller J, Mauss S, Engelbrecht S, Dutt JE, Foster CS, Steuhl KP. Eosinophil granule proteins expressed in ocular cicatrical pemphigoid. Br J Ophthalmol 1998; 82 (3): 312-317.
12. Holland EJ, Olsen TW, Ketcham JM, Florine C, Krachmer JH, Purcell JJ, Lam S, Tessler HH, Sugar J. Topical Cyclosporin A in the Treatment of Anterior Segment Inflammatory Disease. Cornea 1993; 12 (5): 413-419.
13. Kirklin JK, Bourge RC, Naftel DC et al. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience. J Heart Lung Transplant 1994; 13: 444-450.
14. Langman LJ, LeGatt DF, Yatscoff RW. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measuring IMP dehydrogenase activity. Clin Chem 1995; 41: 295-299.
15. Lee SJ, Li Z, Sherman B, Foster CS. Serum levels of tumor necrosis factor-alpha and interleukin-6 in ocular cicatrical pemphigoid. Invest Ophthalmol Vis Sci 1993; 34 (13): 3522-3525.
16. Pichlmayr P, Sadek SA et al. for the European Mycophenolate Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321-1325.
17. Sollinger HW for the US Renal Transplant Mycophenolate Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225-232.
18. Tauber J, Sainz de la Masa M, Foster CS. Systemic chemotherapy for ocular cicatrical pemphigoid. Cornea 1991; 10 (3): 185-195.
19. Taylor DO, Ensley D, Olsen SL, Dunn D, Renlund DG. Mycophenolate mofetil (RS-61443): preclinical, clinical and threeyear experience in heart transplantation. J Heart Lung Transplant 1994; 13: 571-582.
20. Tesavibul N, Dorfman D, Sangwan VS, Christen W, Panayotis Z, Rojas B, Foster CS. Costimulatory molecules in ocular cicatrical pemphigoid. Invest Ophthalmol Vis Sci 1998; 39 (6): 982-988.
21. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029-1033.
22. Tyagi S, Bhol K, Natarajan K, Livir-Ralatos C, Foster CS, Ahmed AR. Ocular cicatrical pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci USA 1996; 93 (25): 14714-14719